We will present quantitative results from inhibitor binding studies using mass photometry. Attendees will find out how to implement mass photometry-based workflows for rapid assessment of RNA integrity, enabling faster troubleshooting and quality checks in RNA production or research. Adopting a label-free strategy for monitoring mRNA stability reduces reliance on traditional, time-consuming assays like gel electrophoresis or chromatography.

• Find out how to overcome common RNA analysis bottlenecks by learning how mass photometry simplifies workflows—no denaturation, labelling, or complex prep required
• Improve data confidence and decision-making with a reliable method to assess mRNA stability and integrity in minutes, not hours or days
• Stay ahead of industry trends by exploring how cutting-edge, label-free technologies are reshaping RNA therapeutic development and quality control
• Discover how to apply mass photometry to evaluate small molecule interactions with RNA, supporting early-stage screening and drug development efforts with quantitative binding data